Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$45.25

0.295 (0.66%)

, CREE

Cree

$25.20

0.4 (1.61%)

10:33
10/19/16
10/19
10:33
10/19/16
10:33

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Market Perform from Outperform at FBR Capital with analyst Paul Miller saying the shares will be range-bound pending greater clarity into the ongoing regulatory investigations and recently announced independent audit. 2. Cree (CREE) downgraded to Equal Weight from Overweight at Stephens with analyst Harsh Kumar citing his belief that the growth as well margin progression has been slower than expected since the ERP issues that hit the company earlier this year. 3. Norwegian Cruise Line (NCLH) downgraded to Hold from Buy at SunTrust with analyst Patrick Scholes citing a recent pricing survey that indicates a broad based slowdown across all global regions. 4. Genesco (GCO) downgraded to Buy from Strong Buy at CL King. 5. Cooper-Standard (CPS) downgraded to Hold from Buy at Jefferies with analyst Bret Jordan saying the valuation looks full with the shares up 23% year-to-date. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

WFC

Wells Fargo

$45.25

0.295 (0.66%)

CREE

Cree

$25.20

0.4 (1.61%)

NCLH

Norwegian Cruise Line

$38.25

0.78 (2.08%)

GCO

Genesco

CPS

Cooper-Standard

$89.56

-5.753 (-6.04%)

  • 23

    Oct

  • 01

    Nov

WFC Wells Fargo
$45.25

0.295 (0.66%)

10/19/16
FBRC
10/19/16
DOWNGRADE
Target $45
FBRC
Market Perform
Wells Fargo downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Paul Miller downgraded Wells Fargo to Market Perform saying the shares will be range-bound pending greater clarity into the ongoing regulatory investigations and recently announced independent audit. The analyst sees too much uncertainty and cut his price target for Wells shares to $45 from $50.
10/17/16
10/17/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Buy at Buckingham and to Market Perform from Outperform at BMO Capital. 2. Wells Fargo (WFC) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl saying the valuation "cannot overcome" all the uncertainty. 3. Lowe's (LOW) downgraded to Buy from Conviction Buy at Goldman with analyst Matthew Fassler saying the home improvement retail sector is closely tied to housing turnover and home improvement sales are also approaching normalized levels. 4. Pandora (P) downgraded to Underperform from Neutral at BofA/Merrill with analyst Nat Schindler saying he believes Pandora's $4B revenue 2020 revenue goal will be difficult to achieve as the on-demand subscription streaming market has become increasingly competitive and the user base is fully penetrated. 5. Time Warner (TWX) downgraded to Neutral from Outperform at Wedbush with analyst James Dix citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/16
10/17/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Market Perform from Underperform at BMO Capital with analyst James Fotheringham. 2. AMD (AMD) upgraded to Perform from Underperform at Oppenheimer with analyst Rick Schafer citing lower balance sheet risk and improved near-term sales trends ahead of the company's third quarter results. 3. Groupon (GRPN) upgraded to Outperform from Neutral at Wedbush with analyst Aaron Turner saying he expects the company's "large valuation discrepancy" relative to peers to close following its third quarter earnings report. 4. Michael Kors KORS) upgraded to Mixed from Negative at OTR Global. 5. PNC Financial (PNC) upgraded to Buy from Hold at Argus with analyst Stephen Biggar saying PNC is well positioned to benefit from rising rates and it is making progress on a range of strategic initiatives, including expansion in the Southeast and in the Chicago area, where increased brand awareness has led to good growth in both retail and commercial banking. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/16
BMOC
10/17/16
UPGRADE
BMOC
Market Perform
Wells Fargo upgraded on valuation at BMO Capital
As noted earlier, BMO Capital upgraded Wells Fargo to Market Perform from Underperform. Analyst James Fotheringham upgraded the stock based on valuation.
CREE Cree
$25.20

0.4 (1.61%)

09/30/16
WILL
09/30/16
INITIATION
Target $23
WILL
Hold
Cree initiated with a Hold at Williams Capital
Williams Capital analyst Cynthia Motz initiated Cree with a Hold and a $23 price target.
10/19/16
10/19/16
DOWNGRADE
Target $25

Equal Weight
Cree downgraded to Equal Weight at Stephens
As previously reported, Stephens analyst Harsh Kumar downgraded Cree to Equal Weight from Overweight on his belief that the growth as well margin progression has been slower than expected since the ERP issues that hit the company earlier this year. The analyst also lowered his price target on the shares to $25 from $35.
10/19/16
SPHN
10/19/16
DOWNGRADE
SPHN
Equal Weight
Cree downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Harsh Kumar downgraded Cree to Equal Weight from Overweight following the company's Q1 report and Q2 guidance, saying the company's execution "continues to be lacking."
10/19/16
GSCO
10/19/16
NO CHANGE
Target $17
GSCO
Sell
Cree's valuation remains rich, says Goldman
Goldman analyst Brian Lee said Cree reported a mixed Q1 and guided Q2 below his expectations. He believes LED remains a source of downside risk on pricing pressure and visibility on a recovery to double-digit sales growth remains low. Lee sees more downside risk to Cree shares given the lack of growth in both lighting and LED and reiterated his Sell rating and lowered his price target to $17 from $18 on shares.
NCLH Norwegian Cruise Line
$38.25

0.78 (2.08%)

10/05/16
10/05/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Barrick Gold (ABX) downgraded to Buy from Conviction Buy at Goldman with analyst Andrew Quail citing increased macro headwinds negatively impacting gold prices. 2. Norwegian Cruise Line (NCLH) downgraded to Neutral from Buy at UBS. 3. Gigamon (GIMO) downgraded to Market Perform from Outperform at Raymond James and to Neutral from Buy at DA Davidson. 4. iRadimed (IRMD) downgraded to Neutral from Buy at Roth Capital. 5. Trinity Biotech (TRIB) downgraded to Equal Weight from Overweight at Stephens with analyst Drew Jones citing the announcement of the withdrawal of Meritas Troponin test from FDA consideration. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/14/16
WEDB
10/14/16
DOWNGRADE
Target $45
WEDB
Neutral
Norwegian Cruise Line downgraded to Neutral from Outperform at Wedbush
Wedbush analyst James Hardiman downgraded Norwegian Cruise Line to Neutral saying the recent trend in his firm's proprietary cruise line pricing analysis has been "decidedly negative." Headlines are likely to get worse before getting better, Hardiman tells investors in a research note. He cut his price target for Norwegian shares to $45 from $53.
10/19/16
RHCO
10/19/16
DOWNGRADE
Target $43
RHCO
Hold
Norwegian Cruise Line downgraded to Hold from Buy at SunTrust
SunTrust analyst Patrick Scholes downgraded Norwegian Cruise Line to Hold from Buy and lowered its price target to $43 from $52 following a recent pricing survey that indicates a broad based slowdown across all global regions. Scholes said Norwegian's pricing went to negative 1.5% in September from +1.3% in August and has decelerated every month since April. The analyst said the company's high-end Prestige brands were especially weak and it appears pricing for Regent Seven Seas took another leg down, something he believes is not reflected in August earnings guidance.
10/19/16
RHCO
10/19/16
NO CHANGE
RHCO
Cruise prices decelerating, says SunTrust
SunTrust analyst C. Patrick Scholes says that a recent survey of cruise prices indicates a broad based slowdown across all global regions. The analyst reports that Carnival's (CCL) advertised prices are up only 1.1%, versus a 6.4% jump previously, while Royal Caribbean's prices dropped 1.5% versus a 5.3% gain previously. Norwegian Cruise Line's (NCLH) prices also declined 1.5%, while "most brands were down sequentially," according to Scholes. The analyst downgraded his rating on Norwegian to Hold from Buy and cut his price target on that stock to $43 from $52. He reduced his price target on Royal Caribbean to $92 from $97 and lowered his price target on Carnival to $54 from $57. However, the analyst keeps Buy ratings on the latter two stocks.
GCO Genesco

09/02/16
BARD
09/02/16
DOWNGRADE
BARD
Neutral
Genesco downgraded to Neutral from Outperform at Baird
07/20/16
MSCO
07/20/16
DOWNGRADE
MSCO
Equal Weight
Genesco downgraded to Equal Weight on slowing sales at Morgan Stanley
Morgan Stanley analyst Jay Sole downgraded Genesco to Equal Weight citing slower than expected US footwear trends and the impact from Brexit. Sole said Schuh division sales have slowed noticeably since Brexit and no longer sees a major opportunity for upward earnings revisions. The analyst lowered Genesco's price target to $74 from $79.
09/15/16
SUSQ
09/15/16
INITIATION
Target $57
SUSQ
Positive
Genesco initiated with a Positive at Susquehanna
Susquehanna analyst Sam Poser initiated Genesco with a Positive and a $57 price target.
10/19/16
KING
10/19/16
DOWNGRADE
KING
Buy
Genesco downgraded to Buy from Strong Buy at CL King
CPS Cooper-Standard
$89.56

-5.753 (-6.04%)

10/19/16
JEFF
10/19/16
DOWNGRADE
Target $105
JEFF
Hold
Cooper-Standard downgraded to Hold from Buy at Jefferies
Jefferies analyst Bret Jordan downgraded Cooper-Standard to Hold saying the valuation looks full with the shares up 23% year-to-date. The analyst also expects decelerating North America market growth due to cyclical slowdown. He keeps a $105 price target for the stock.
09/27/16
BUCK
09/27/16
DOWNGRADE
Target $105
BUCK
Neutral
Cooper-Standard downgraded to Neutral from Buy at Buckingham
Buckingham downgraded Cooper-Standard to Neutral citing balanced risk/reward and raised its price target to $105 from $101.
09/19/16
ROTH
09/19/16
NO CHANGE
Target $115
ROTH
Buy
Cooper-Standard price target raised to $115 from $105 at Roth Capital
Roth Capital analyst Matt Koranda raised his price target for Cooper-Standard to $115 from $105, saying he has increased confidence in the company's $100M of targeted cost efficiency for 2016 and expects sustained implementation of the Cooper Standard Operating System to drive EBITDA margin improvement annually through 2018 and beyond. The analyst reiterates a Buy rating on the shares.
08/09/16
GHSC
08/09/16
INITIATION
Target $108
GHSC
Buy
Cooper-Standard initiated with a Buy at Seaport Global
Seaport Global analyst Michael Ward initiated Cooper-Standard with a Buy and $108 price target.

TODAY'S FREE FLY STORIES

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

, GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
UT Health Science Center to hold a symposium »

2016 San Antonio Breast…

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

MYGN

Myriad Genetics

$17.40

0.41 (2.41%)

RDUS

Radius Health

$43.94

-3.13 (-6.65%)

OCX

OncoCyte

$6.15

0.05 (0.82%)

ABBV

AbbVie

$61.54

0.64 (1.05%)

BAYRY

Bayer

$100.04

1.14 (1.15%)

CELG

Celgene

$113.47

0.41 (0.36%)

CLDX

Celldex

$3.75

0.01 (0.27%)

DNA

Bought by RHHBY

HRTX

Heron Therapeutics

$14.90

-0.55 (-3.56%)

PFE

Pfizer

$31.70

0.76 (2.46%)

PBYI

Puma Biotechnology

$36.50

0.05 (0.14%)

TSRO

TESARO

$129.97

-1.57 (-1.19%)

NSTG

NanoString

$21.79

-0.35 (-1.58%)

NVS

Novartis

$69.74

2.15 (3.18%)

NVTA

Invitae

$7.24

0.28 (4.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

BBSI

Barrett Business

$62.30

1.85 (3.06%)

, BREW

Craft Brew

$16.65

0.45 (2.78%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
Roth Capital to hold a conference »

5th Annual ROTH Utah…

BBSI

Barrett Business

$62.30

1.85 (3.06%)

BREW

Craft Brew

$16.65

0.45 (2.78%)

CHKE

Cherokee

$11.10

-0.35 (-3.06%)

DFBG

Differential Brands

$3.20

0.25 (8.47%)

DLA

Delta Apparel

$20.77

-0.39 (-1.84%)

ESCA

Escalade

$13.65

-0.15 (-1.09%)

FLKS

Flex Pharma

$6.29

-0.01 (-0.16%)

KONA

Kona Grill

$12.75

0.05 (0.39%)

LNDC

Landec

$15.05

-0.25 (-1.63%)

MEET

MeetMe

$5.63

0.16 (2.93%)

MITK

Mitek Systems

$6.50

0.35 (5.69%)

MB

MINDBODY

$20.70

-0.25 (-1.19%)

OSIS

OSI Systems

$78.17

1.22 (1.59%)

PLNT

Planet Fitness

$21.01

-0.07 (-0.33%)

ROX

Castle Brands

$0.75

0.0309 (4.30%)

PRTS

U.S. Auto Parts

$3.33

0.09 (2.78%)

RSYS

RadiSys

$4.77

0.11 (2.36%)

SWHC

Smith & Wesson

$21.07

-0.16 (-0.75%)

VSTO

Vista Outdoor

$38.62

-1.24 (-3.11%)

WMAR

West Marine

$9.41

0.13 (1.40%)

ZAGG

ZAGG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDEX

PRO-DEX

$4.48

0.034 (0.76%)

17:06
12/09/16
12/09
17:06
12/09/16
17:06
Syndicate
Breaking Syndicate news story on PRO-DEX »

PRO-DEX files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFBX

Peoples Financial

$14.50

-0.5 (-3.33%)

17:02
12/09/16
12/09
17:02
12/09/16
17:02
Hot Stocks
Breaking Hot Stocks news story on Peoples Financial »

Jeffrey L. Gendell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUIK

QuickLogic

$0.94

-0.0163 (-1.71%)

17:00
12/09/16
12/09
17:00
12/09/16
17:00
Syndicate
Breaking Syndicate news story on QuickLogic »

QuickLogic files $40M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRZA

Starz

17:00
12/09/16
12/09
17:00
12/09/16
17:00
Hot Stocks
Breaking Hot Stocks news story on Starz »

Elliott Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEL

Belmond

16:55
12/09/16
12/09
16:55
12/09/16
16:55
Syndicate
Breaking Syndicate news story on Belmond »

Belmond files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

16:55
12/09/16
12/09
16:55
12/09/16
16:55
Hot Stocks
Breaking Hot Stocks news story on Parnell »

Parnell trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$43.73

0.15 (0.34%)

, SHAK

Shake Shack

$38.08

0.82 (2.20%)

16:50
12/09/16
12/09
16:50
12/09/16
16:50
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Shake Shack »

Morgan Stanley reports…

MS

Morgan Stanley

$43.73

0.15 (0.34%)

SHAK

Shake Shack

$38.08

0.82 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.